INTRODUCTION {#sec1-1}
============

Alarge number of plants are being increasingly used in the treatment of pain and inflammatory conditions.\[[@ref1][@ref2]\] The preference to the herbal agents is more compared to conventional non-steroidal anti-inflammatory drugs (NSAIDs) because NSAIDs administration is associated with the risk of producing adverse effects such as gastric ulceration, thrombocytopenia, skin rashes.\[[@ref3]\] Plant based medicines are widely used in Ayurvedic system of medicine as *Vedana śāmaka* or *śothahara*.\[[@ref4]\] Thus, there is growing interest in the pharmacological evaluation of various plants used in the Indian traditional system of medicine for treatment of inflammatory conditions.

*Grewia asiatica* Linn. (Family: Tiliaceae), called *Phalsa* in Hindi, *Alpāsthi* in Sanskrit is cultivated on a commercial scale mainly in the Northern and Western states of India.\[[@ref5][@ref6]\] It is known for its medicinal properties. In this, the fruit possesses astringent, cooling and stomachic properties. It is reported that unripe Phalsa fruit alleviates inflammation and is administered in respiratory, cardiac and blood disorders. It is also used for fever reduction. The fruits are also documented to have antimalarial and anti-ulcer effect.\[[@ref7]\] A polyherbal preparation-PD10, which contains fruits of *G. asiatica* as an important constituent has been demonstrated to possess antipyretic-analgesic activity in animals.\[[@ref7]\] The leaves are applied on pustular skin eruptions and they are known to have antibiotic action.\[[@ref8][@ref9]\] The infusion of the bark is given as a demulcent, febrifuge and is also used in the treatment of diarrhoea. In traditional uses, the Santal tribes use the root-bark of *G. asiatica* for treating rheumatism.\[[@ref10][@ref11]\]

In view of the traditional use of root bark of *G. asiatica* in rheumatism, a painful chronic inflammatory condition, we thought it worthwhile to investigate analgesic and anti-inflammatory effect of methanolic extract of *Grewia asiatica* and aqueous extract of *Grewia asiatica* (MEGA and AEGA) root bark of *G. asiatica* in the experimental models of pain and inflammation.

MATERIALS AND METHODS {#sec1-2}
=====================

Plant material {#sec2-1}
--------------

The root barks of *G. asiatica* were collected from Jorasi village, Gwalior in the month of January and authenticated by a Taxonomist of the National Research Institute for Ayurveda-Siddha Human Resource Development, Gwalior.

Preparation of plant extracts {#sec2-2}
-----------------------------

The barks were shade dried and coarsely powdered. The powder was subjected to defatting in soxhlet apparatus using petroleum ether at 60-80°C. After this, MEGA was collected using 95% methanol in soxhlet apparatus. The soxhlet extraction of bark powder with methanol was carried out until the complete extraction. The AEGA was collected using cold maceration for 72 h. The solvents were completely removed under reduced pressure using rotary evaporator to get the yield 12.69% and 13.01% w/w, respectively.

Phytochemical screening of the extracts {#sec2-3}
---------------------------------------

The extracts (MEGA and AEGA) were subjected to various tests to study the presence of different phytochemical constituents (carbohydrates, proteins, fats and oils, sterols, glycosides, flavonoids, alkaloids, phenolic compounds and tannins) using established methods \[[Table 1](#T1){ref-type="table"}\].\[[@ref12]\]
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Experimental animals {#sec2-4}
--------------------

Male Swiss albino mice (22-25 g) and Wistar rats (220-250 g) were used for assessment of analgesic activity while male Wistar rats (220-250 g) were used for assessment of anti-inflammatory activity. Animals were bred and maintained at Central Animal Facility of the Institute under standard housing conditions of temperature 25 ± 2°C, relative humidity 55-65% and light and dark cycles of 12 h, respectively. Animals were provided with standard pellet diet (Ashirwad brand, Chandigarh) and water *ad libitum*. Principles of laboratory animal care guidelines were followed and prior permission was sought from the Institute Animal Ethics Committee for conducting the experiments (proposal no. CRI-GWL/IAEC/2010/03).

Drugs and chemicals {#sec2-5}
-------------------

Indomethacin (IND) (Alfa remedies, Ambala) was obtained as gift sample. Sodium carboxymethylcellulose (Himedia, Mumbai) was procured from local market. Carrageenan was procured from Sigma Aldrich, USA. Pentazocine (Fortwin, Ranbaxy Laboratories Ltd., Ahmedabad) was purchased in injectable form. Drug solutions were freshly prepared and their doses are expressed in terms of their free bases.

Doses and treatments {#sec2-6}
--------------------

Mice and rats were divided into six different groups (*n* = 5). MEGA was suspended in 0.5% sodium carboxymethylcellulose in normal saline while AEGA was solubilised as such for administration purpose. MEGA and AEGA were administered in graded doses of 200 and 400 mg/kg, orally. The doses selected were based on acute toxicity study and previous reports.\[[@ref13][@ref14]\] The extracts and standard drugs were given in volume of 10 ml/kg, orally and 5 ml/kg, intra-peritoneally (i.p.) All rodents were fasted for 12 h before starting the test.

Acute toxicity study {#sec2-7}
--------------------

The acute oral toxicity study was carried out according to Organisation for Economic Cooperation and Development (OECD) guidelines 423. The limit test for acute toxicity of MEGA and AEGA was carried out in the dose of 2000 mg/kg, orally, in rats. The rats were observed for a period of 72 h and thereafter up to 14 days for behavioural, neurological, autonomic profiles and for any lethality, moribund state, or death.\[[@ref15]\]

Assessment of analgesic activity {#sec2-8}
--------------------------------

### Assessment of peripheral analgesic effect of MEGA and AEGA {#sec3-1}

The peripheral analgesic effect of MEGA and AEGA was evaluated using acetic acid-induced writhing test model.\[[@ref16]\] Writhing is defined as stretch, torsion to one side, retraction of the abdomen and opisthotonous so that the belly of the mouse touches to the floor. Abdominal writhing episodes were induced in mice by i.p. injection of acetic acid (10 ml/kg of 0.6%). IND (10 mg/kg, orally) was used as standard drug.\[[@ref17]\] Mice were pre-treated with vehicle or MEGA or AEGA or IND 1 h prior to acetic acid injection and thereafter the observations were made. The number of stretchings occurred immediately within 30 min after the acetic acid injection was recorded. The results were evaluated by calculating the mean number of stretching per group and represented as % inhibition of stretching movement compared with the control group as below:

\% Analgesic activity = (*n* − *n*′/*n*) ×100

where *n* is the average number of stretchings in the control group and *n*′ is the average number of stretching in the test group.

### Assessment of central analgesic effect of MEGA and AEGA {#sec3-2}

The central analgesic effect of MEGA and AEGA was studied using Eddy\'s hot plate test.\[[@ref18]\] The rats were placed on the hot plate maintained at 55 ± 1°C and time in seconds for the paw licking or jumping was recorded as the reaction time. Rats, which have shown basal reaction time period below 6 s, were selected and used for the screening. Pentazocine (5 mg/kg) was administered i.p. as standard drug. Rats were pre-treated with vehicle or MEGA or AEGA or pentazocine. The activity of the rats on the hot plate was closely observed and the reaction time (latency period) was recorded in seconds as the time taken for the animal to react to the thermal pain by licking its paw or attempting to jump out.

### Assessment of anti-inflammatory activity {#sec3-3}

The anti-inflammatory activity was assessed using carrageenan-induced paw oedema in the rat model.\[[@ref19]\] Acute paw oedema (acute inflammation) was induced by sub-plantar injection of carrageenan suspension (0.1 ml of 1% w/v freshly prepared suspension in normal saline) into the right hind paw of each rat. The left hind paw was injected with the same volume of 0.1 ml of normal saline. IND (10 mg/kg, orally) was used as standard drug.\[[@ref20]\] Rats were pre-treated with vehicle or MEGA or AEGA or IND 1 h prior to carrageenan administration. The paw size was measured in mm using vernier caliper before (0 min) and at 1^st^ and 3^rd^ h after carrageenan administration. The percent inhibition was calculated by the following formula:

Percentage inhibition = (*C*~t~ − *C*~o~)~control~ − (*C*~t~ − *C*~o~)~treated~/(*C*~t~ − *C*~o~)control

where *C*~t~ = Thickness of paw after carrageenan injection and *C*~o~ = Thickness of paw before carrageenan injection

Statistical analysis {#sec2-9}
--------------------

Data were analysed by one-way analysis of variance (ANOVA) and one-way repeat measure ANOVA, wherever applicable followed by Dunnett\'s *post hoc* test. The difference of *P* \< 0.05 was considered as significant in all cases.

RESULTS {#sec1-3}
=======

Phytochemical screening {#sec2-10}
-----------------------

The phytochemical screening of MEGA and AEGA revealed the presence of flavonoids, phenolic compounds, tannins, triterpenoid, sterols, mucilage, gum, protein, amino acid, carbohydrate and glycosides \[[Table 1](#T1){ref-type="table"}\].

Acute toxicity study {#sec2-11}
--------------------

The limit test for acute toxicity showed that rats receiving MEGA and AEGA at 2000 mg/kg, orally, exhibited normal behavioural, neurological and autonomic profiles. No mortality or toxicity of any nature was observed during 72 h and thereafter up to 14 days observation. This indicated that approximate LD~50~ value of MEGA and AEGA is more than 2000 mg/kg, orally and it is relatively safe and non-toxic to rats.

Assessment of analgesic activity {#sec2-12}
--------------------------------

### Peripheral analgesic effect of MEGA and AEGA on acetic acid-induced writhing test in mice {#sec3-4}

One-way ANOVA revealed a significant (*P* \< 0.0001) influence of MEGA and AEGA on acetic acid-induced writhing compared to control \[[Figure 1](#F1){ref-type="fig"}\]. *Post hoc* Dunnett\'s test showed that MEGA and AEGA at 400 mg/kg, caused significant inhibition (*P* \< 0.01) of writhing, but lower dose of the extracts did not exhibit inhibition of writhing (*P* \> 0.05). The maximum inhibition for MEGA and AEGA at 400 mg/kg noted was 41.14% and 46.24%, respectively. The effects were comparable with that of reference standard, IND that also showed significant inhibition (36.04%) of writhing (*P* \< 0.01) \[[Figure 1](#F1){ref-type="fig"}\].

![Mice were pre-treated with vehicle or methanolic extract of *Grewia asiatica* or aqueous extract of *Grewia asiatica* (200 and 400 mg/kg, orally) or indomethacin (10 mg/kg, orally) 1 h prior to acetic acid injection. The number of stretching\'s occurred immediately within 30 min after the acetic acid injection was recorded. The results are represented as % inhibition of stretching movement. Results are expressed as mean ± standard error of the mean. (*n* = 5 mice) \**P* \< 0.01 versus control (one-way analysis of variance followed by *post hoc* Dunnett\'s test). Value in parenthesis shows percentage inhibition of writhings](ASL-32-150-g002){#F1}

### Central analgesic effect of MEGA and AEGA on the hot plate test in mice {#sec3-5}

One-way repeat measure ANOVA analysis of the data generated showed significant (*P* \< 0.0001) influence of MEGA and AEGA on the hot plate reaction time \[[Table 2](#T2){ref-type="table"}\]. Dunnett\'s test showed that MEGA and AEGA at 400 mg/kg, showed significant (*P* \< 0.01, *P* \< 0.05, respectively) increase in reaction time, but MEGA and AEGA at 200 mg/kg, did not show any significant effect on reaction time compared with the control group (*P* \> 0.05). MEGA and AEGA at 400 mg/kg produced maximum effect and increased reaction time from 4.00 to 12.37 s and 3.40-12.00 s, respectively at the end of 180 min. The effect of MEGA and AEGA was comparable with pentazocine that showed a significant increase (*P* \< 0.001) in reaction time from 4.80 s to 13.00 s at the end of 180 min \[[Table 2](#T2){ref-type="table"}\].
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### Anti-inflammatory effect of MEGA and AEGA on carrageenan-induced rat paw oedema {#sec3-6}

One-way repeat measure ANOVA analysis of the generated data showed significant (*P* \< 0.0001) influence of MEGA and AEGA on carrageenan-induced inflammation \[[Table 3](#T3){ref-type="table"}\]. Dunnett\'s test indicated MEGA and AEGA at 400 mg/kg, caused significant (*P* \< 0.01, *P* \< 0.05 respectively) decrease in paw oedema as indicated by increased percent inhibition of paw oedema compared to vehicle. The percent inhibition was found to be 59.14 and 53.04%, respectively. MEGA and AEGA at 200 mg/kg did not show any significant effect (*P* \> 0.05). IND at 10 mg/kg showed a significant and maximum reduction of paw oedema with 64.02% inhibition in comparison with the control group at 3^rd^ h. The effects of MEGA and AEGA were comparable to IND that showed maximum decrease in paw oedema compared with vehicle \[[Table 3](#T3){ref-type="table"}\].
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DISCUSSION {#sec1-4}
==========

The results of the analgesic test experiments suggest that *G. asiatica* exhibits both peripheral and central analgesic properties. Acetic acid-induced writhing and hot plate test methods are useful techniques for the evaluation of peripherally and centrally acting analgesic drugs, respectively.\[[@ref21][@ref22]\] The MEGA and AEGA of the root bark of *G. asiatica* exhibited significant dose dependent inhibition of acetic acid-induced writhing in mice, comparable to IND while delayed the reaction times of rats in the 'hot plate' analgesia in a dose dependent fashion, comparable to pentazocine. The peripheral analgesic effect is generally mediated through inhibition of cyclooxygenase and/or lipoxygenase (and other inflammatory mediators) or inhibition of pain responses mediated by noiceptors peripherally\[[@ref21][@ref23]\] while the central analgesic action is mediated via inhibition of central pain receptors.\[[@ref24][@ref25]\] Therefore, it is possible that MEGA and AEGA may be showing analgesic effect through these mechanisms. An earlier study on the polyherbal formulation-PD-10 has shown it to possess antipyretic-analgesic activity in animals\[[@ref7]\] and this formulation contains fruits of *G. asiatica* as an important constituent. In another ethnobotanical survey study,\[[@ref26]\] it is mentioned that roots paste of *G. asiatica* is used in backache. Thus, the above studies support the analgesic effect of the extracts and strengthen the findings.

The carrageenan-induced rat paw oedema is a suitable test for evaluating anti-inflammatory drugs.\[[@ref22]\] Development of the oedema in the paw of the rat after injection of carrageenan is a biphasic event. The initial phase observed during the 1^st^ h is attributed to the release of histamine and serotonin while the second phase of oedema is due to the release of prostaglandins, proteases and lysosomes.\[[@ref27][@ref28]\] In carrageenan paw oedema model of acute inflammation, MEGA and AEGA showed significant dose dependent reduction in paw size both at 1^st^ and 3^rd^ h and elicited anti-inflammatory response comparable with IND. This might be due to the inhibition of the biphasic response induced by the carrageenan. It is possible that acute anti-inflammatory effect of MEGA and AEGA may involve multiple mechanisms like inhibition of either cyclo-oxygenase and/or lypo-oxygenase enzyme or inhibition of synthesis, release and action of above inflammatory mediators. This is in agreement with the generally believed thinking that herbal preparations may involve multiple sites in their actions.\[[@ref29]\] In previous studies, several plants showing anti-inflammatory effects have been suggested to act through these mechanisms.\[[@ref30][@ref31][@ref32]\] The recent review\[[@ref33]\] on *G. asiatica* has also not cited any study indicating the analgesic and anti-inflammatory effect of root bark suggesting that these effects have not been studied yet. The present investigation is probably the first to report the analgesic and anti-inflammatory action of the root bark in experimental animals.

Several plant extracts showed analgesic and anti-inflammatory effect in animal models and their effects have been attributed to the presence of triterpenoids, alkaloids, glycosides, flavonoids, tannins, saponins and sterols.\[[@ref34][@ref35][@ref36][@ref37][@ref38][@ref39]\] The phytochemical screening of MEGA and AEGA revealed the presence of most of the above-mentioned phytochemicals. The previous studies have also reported the presence of these phytochemicals such as kaempherol, quercetin, naringenin and their glucosides, grewinol, taxasterol, sitosterol, citric acid, arabinose, etc., in one or different parts of *G. asiatica*.\[[@ref7][@ref33]\] Therefore, it is possible that the analgesic and anti-inflammatory activity of MEGA and AEGA can be due to the presence of these phytochemical constituents. As the extracts possess both analgesic and anti-inflammatory effect, it is suggested that roots bark may be very effective in rheumatism (painful inflammatory condition). However, the assessment of analgesic and anti-inflammatory needs to be carried out in animal models of rheumatism like Freund adjuvant or collagen induced arthritis to further substantiate its claim in treatment of rheumatism.

CONCLUSION {#sec1-5}
==========

It can be concluded that the root bark of *G. asiatica* has potential analgesic and anti-inflammatory activity. This study substantiates the traditional use of bark of *G. asiatica* in rheumatism. Further bioactivity guided studies are required to determine the exact constituent responsible for the analgesic and anti-inflammatory effect of *G. asiatica*.
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